Roche to buy U.S. cancer drugmaker Ignyta for $1.7 billion(Reuters) - Swiss drugmaker Roche will buy U.S. cancer drugmaker Ignyta Inc for $1.7 billion to broaden its oncology portfolio globally, the companies said on Friday.
from Reuters: Business News http://ift.tt/2CUVRFy
…Read More
This year's lumps of coal could be 2018's diamondsSAN FRANCISCO (Reuters) - Investors saddled in 2017 with the market's worst performers, including Under Armour and General Electric, may do well to remember as December draws to an end that lumps of coal sometimes turn into d…Read More
Alphabet's Eric Schmidt to step down as executive chairmanSAN FRANCISCO (Reuters) - Alphabet Inc said on Thursday its Executive Chairman Eric Schmidt will step down in January, ending a 17-year-run in which he played a central role in building a promising startup called Google into …Read More
0 comments:
Post a Comment